Bluejay Diagnostics, Inc. received a notice from Nasdaq for not meeting the minimum bid price requirement of $1.00 per share, but has been given until February 24, 2025, to regain compliance, potentially through a reverse stock split; additionally, stockholders approved an increase in authorized shares from 50 million to 250 million and changes to warrant terms allowing for the issuance of approximately 21.5 million shares.